PeerJ · 2016 · 33 citations · 25 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial AgentsAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceBacterial BiofilmsBiofilm Formation In InfectionAntibiotic Susceptibility TestingAntimicrobial Resistance In BiofilmsBiofilm-associated Antimicrobial ResistanceBiofilm-disrupting AgentsMinimum Inhibitory Concentration TestingMycobacterium Tuberculosis InfectionMycobacterium Tuberculosis PathogenesisTuberculosis Drug Resistance
Much is known regarding the antibiotic susceptibility of planktonic cultures of Mycobacterium tuberculosis , the bacterium responsible for the lung disease tuberculosis (TB). As planktonically-grown M. tuberculosis are unlikely to be entirely representative of the bacterium during infection, we set out to determine how effective a range of anti-mycobacterial treatments were against M. tuberculosis growing as a biofilm, a bacterial phenotype known to be more resistant to antibiotic treatment. Light levels from bioluminescently-labelled M. tuberculosis H37Rv (strain BSG001) were used as a surrogate for bacterial viability, and were monitored before and after one week of treatment. After treatment, biofilms were disrupted, washed and inoculated into fresh broth and plated onto solid media to rescue any surviving bacteria. We found that in this phenotypic state M. tuberculosis was resistant to the majority of the compounds tested. Minimum inhibitory concentrations (MICs) increased by 20-fold to greater than 1,000-fold, underlying the potential of this phenotype to cause significant problems during treatment.
25
Global tuberculosis report (2014)
L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations
Howard Ceri, Merle S. Olson, Carol A. Stremick et al. · Journal of Clinical Microbiology · 1999 · 2.1K citations · Full text
Lorena Tuchscherr, Eva Medina, Muzaffar Hussain et al. · EMBO Molecular Medicine · 2011 · 436 citations · Full text